✦ LIBER ✦

White matter changes in early-onset Alzheimer's disease brains

✍ Scribed by Takahiko Umahara; Kuniaki Tsuchiya; Akihiro Kiuchi; Kiyoshi Kanaya; Toshihiko Iwamoto; Masaru Takasaki

Book ID: 109005191
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 279 KB
Volume: 4
Category: Article
ISSN: 1444-1586
DOI: 10.1111/j.1447-0594.2004.00252.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Vascular changes in white matter lesions

Vascular changes in white matter lesions of Alzheimer’s disease

✍ H. Tomimoto; Ichiro Akiguchi; Haruhiko Akiyama; Kenji Ikeda; Hideaki Wakita; Jin 📂 Article 📅 1999 🏛 Springer-Verlag 🌐 English ⚖ 226 KB

Early complement components in Alzheimer

Early complement components in Alzheimer's disease brains

✍ R. Veerhuis; I. Janssen; C.E. Hack; P. Eikelenboom 📂 Article 📅 1995 🏛 Springer-Verlag 🌐 English ⚖ 467 KB

White matter hyperintensities and change

White matter hyperintensities and changes in white matter integrity in patients with Alzheimer’s disease

✍ Liya Wang; Felicia C. Goldstein; Allan I. Levey; James J. Lah; Carolyn C. Meltze 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 428 KB

Brain atrophy and white matter hyperinte

Brain atrophy and white matter hyperintensities in early Parkinson's disease

✍ Turi O. Dalaker; Jan P. Larsen; Niels Bergsland; Mona K. Beyer; Guido Alves; Mic 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB 👁 1 views

## Abstract The purpose of this research was to examine the extent of global brain atrophy and white matter hyperintensities (WMH) in early Parkinson's disease (PD) compared to normal controls (NC), to explore the relationship between the MRI variables and cognition in PD. In this multicenter study

Morphology of white matter dementia in A

Morphology of white matter dementia in Alzheimer's disease

✍ A. Brun; L. Gustafson; Elisabet Englund 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 70 KB

Hypertension, white matter change and re

Hypertension, white matter change and response to cholinesterase inhibitors in Alzheimer's disease

✍ Peter J. Connelly; Neil P. Prentice; Kenneth G. Fowler 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB 👁 1 views

Background Cholinesterase inhibitors are used to treat mild to moderate Alzheimer's disease. Their role in patients with concurrent cerebrovascular disease has been less well studied, and the influence of vascular risk factors on response to treatment is uncertain. We investigated the effect of hype